• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.620 -0.010 (-0.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,108
Open 1.580
Bid (Size) 1.600 (3)
Ask (Size) 1.680 (286)
Prev. Close 1.630
Today's Range 1.530 - 1.625
52wk Range 1.400 - 4.200
Shares Outstanding 31,056,238
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
August 19, 2025
From Inhibikase Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
August 18, 2025
 
Via Benzinga

Performance

YTD
-50.8%
-50.8%
1 Month
+1.3%
+1.3%
3 Month
-10.0%
-10.0%
6 Month
-14.7%
-14.7%
1 Year
+1.9%
+1.9%

More News

Read More
These stocks are moving in today's pre-market session
August 18, 2025
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 18, 2025
Via Benzinga
Inhibikase Posts Wider Loss in Q2
August 14, 2025
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 30, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 27, 2025
Via Benzinga
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
May 14, 2025
From Inhibikase Therapeutics
Via GlobeNewswire
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
April 14, 2025
From Inhibikase Therapeutics
Via GlobeNewswire
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
March 27, 2025
From Inhibikase Therapeutics
Via GlobeNewswire
Inhibikase Announces Expansion of Senior Leadership Team
February 24, 2025
From Inhibikase Therapeutics
Via GlobeNewswire
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
February 18, 2025
From Inhibikase Therapeutics
Via GlobeNewswire
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
February 12, 2025
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
January 30, 2025
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Wednesday?
January 29, 2025
Via Chartmill
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
November 14, 2024
From Inhibikase Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
November 08, 2024
Via Benzinga
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 08, 2024
Via Benzinga
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
October 24, 2024
Via Benzinga
Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension
October 21, 2024
From Inhibikase Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 14, 2024
Via Benzinga
Dow Surges 350 Points; US Crude Oil Stocks Increase
October 09, 2024
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 09, 2024
Via Benzinga
Crude Oil Edges Lower; US Wholesale Inventories Rise 0.1% In August
October 09, 2024
Via Benzinga
Why Inhibikase Therapeutics (IKT) Stock Is Up 50% Today
October 09, 2024
Via Benzinga

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.620
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 10/14/25 04:00 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 50.31M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 50M shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.19
+1.55 (0.63%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap